Earnings Call · Q4 FY2024·2025-02-27

Q4 24EPS +27.63%·Rev n/aQ3 24EPS +21.33%·Rev n/aQ2 24EPS +18.67%·Rev n/aQ1 24EPS +9.72%·Rev n/a⚠ consensus missing

LISATA THERAPEUTICS, INC. LSTA

John Menditto — Investor Relations

David Mazzo — President and Chief Executive Officer

James Nisco — Chief Financial Officer

Kristen Buck — Executive Vice President

−0.8%1d on move date−2.4% vs SPY3d−10.4%5d−2.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LSTA calls or request research access.

More LSTA calls Browse calls Request research access